AB 1823 California Assembly · 2015-2016 Regular Session

California Cancer Clinical Trials Program.

Summary
Existing law, the Inclusion of Women and Minorities in Clinical Research Act, requires a grantee, defined to include, but not be limited to, a college or university that conducts clinical research using state funds, to ensure that women and minority groups are included as subjects in each research project, except as provided. Existing law establishes the University of California. This bill would provide for the establishment of the California Cancer Clinical Trials Program and would request that the University of California establish or designate an institute or office within the university to administer the program, which would be governed by a board of at least 5 members appointed by the president of the university. The bill would authorize the program administrator to solicit funds from various specified sources for purposes of the program and would require the program administrator, upon receipt of at least $500,000 in funding, to establish the Cancer Clinical Trials Grant Program to increase patient access to eligible cancer clinical trials in underserved or disadvantaged communities and populations, as specified.
Bill status signed all 5 stages cleared
Introduction
Feb 2016
Committee Review
Aug 2016
Assembly Passage
Jun 2016
Senate Passage
Aug 2016
Signed into Law
Sep 2016
Introduced Feb 8, 2016 Signed Sep 26, 2016
Floor votes · Senate Aug 23, 2016 · Assembly Jun 1, 2016

How they voted

34–0
Passed
Total votes 34
Aug 23, 2016
D Democratic24
24 Yea
100% Yea
R Republican10
10 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
33
Key actions
8
Committee
13
Amendments
6
Sep 26, 2016
Signed into law
Approved by the Governor.
legislature
Aug 29, 2016
Lower · Passed
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 80. Noes 0. Page 6362.).
lower
Aug 24, 2016
Introduced
In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 26 pursuant to Assembly Rule 77.
lower
Aug 23, 2016
Senate · Passed
Senate Vote: pass (34-0)
senate
Aug 11, 2016
Upper · Passed
From committee: Do pass. (Ayes 7. Noes 0.) (August 11).
upper
Aug 8, 2016
Committee
Referred to APPR. suspense file.
upper
Aug 2, 2016
Committee
Read second time and amended. Re-referred to Com. on APPR.
upper
Aug 1, 2016
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (June 29).
upper
Jun 23, 2016
Committee
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on ED.
upper
Jun 23, 2016
Committee
From committee: Do pass and re-refer to Com. on ED. with recommendation: To Consent Calendar. (Ayes 9. Noes 0.) (June 22). Re-referred to Com. on ED.
upper
Jun 9, 2016
Committee
Referred to Coms. on HEALTH and ED.
upper
Jun 1, 2016
Assembly · Passed
Assembly Vote: pass (75-0)
assembly
May 27, 2016
Lower · Passed
Read second time and amended. Ordered returned to second reading.
lower
May 27, 2016
Introduced
From committee: Amend, and do pass as amended. (Ayes 20. Noes 0.) (May 27).
lower
Apr 27, 2016
Committee
In committee: Set, first hearing. Referred to APPR. suspense file.
lower
Apr 20, 2016
Committee
From committee: Do pass and re-refer to Com. on APPR. (Ayes 13. Noes 0.) (April 19). Re-referred to Com. on APPR.
lower
Apr 13, 2016
Committee
Re-referred to Com. on HIGHER ED.
lower
Mar 28, 2016
Committee
Re-referred to Com. on HIGHER ED.
lower
Mar 17, 2016
Lower · Passed
Read second time and amended.
lower
Mar 16, 2016
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on HIGHER ED. (Ayes 17. Noes 0.) (March 15).
lower
Feb 25, 2016
Committee
Referred to Coms. on HEALTH and HIGHER ED.
lower
Feb 9, 2016
Lower · Passed
From printer. May be heard in committee March 10.
lower
0 primary · 1 co-sponsor

Sponsors

No sponsor information available.